4//SEC Filing
Leftwich Scott 4
Accession 0001493152-24-001132
CIK 0001855485other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 7:49 PM ET
Size
8.2 KB
Accession
0001493152-24-001132
Insider Transaction Report
Form 4
Leftwich Scott
Director
Transactions
- Award
Common Stock
2023-12-21$1.80/sh+8,958$16,124→ 469,903 total - Award
Non-Qualified Stock Options (right to buy)
2023-12-21+70,249→ 70,249 totalExercise: $1.80Exp: 2033-12-21→ Common stock (70,249 underlying)
Footnotes (2)
- [F1]Pursuant to the Issuer's 2023 Equity Incentive Plan (the "2023 Plan"), on December 21, 2023 (the "Grant Date"), the Reporting Person was granted 70,249 Non-Qualified Stock Options (the "Options") at an exercise price of $1.80, which is equal to the closing price of the Issuer's common stock on December 21, 2023, for serving as a director. Options will vest in one year or at the next annual shareholder meeting, whichever occurs first. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person.
- [F2]Represents a grant of restricted stock units ("RSUs") subject to the conditions of the Restricted Stock Unit Award Agreement pursuant to the Issuer's 2023 Plan. Each RSU represents a right to receive one share of the Company's common stock upon vesting. The number of RSUs to be issued will equal to the amount due to the director for Board fees divided by the closing price for a share of the Issuer's common stock of $1.80. The RSUs were granted in a transaction exempt under Rule 16b-3 to the Reporting Person. The shares of common stock underlying the RSUs immediately vested on the Grant Date.
Documents
Issuer
Calidi Biotherapeutics, Inc.
CIK 0001855485
Entity typeother
Related Parties
1- filerCIK 0001991668
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 7:49 PM ET
- Size
- 8.2 KB